Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Photo Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112142680B details a metal-free visible light method for 3-trifluoroalkylquinoxalinones, offering cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN108586527B reveals a metal-free visible light method for aryl phosphonates. Discover cost reduction in pharmaceutical intermediates manufacturing and scalable green synthesis.
Novel visible-light mediated synthesis of 2-acyl-9H-pyrrolo[1,2-a]indoles from N-propargyl indoles. Offers mild conditions, high yield, and scalable routes for pharmaceutical intermediates.
Patent CN111039737B reveals a visible-light catalyzed route for sulfone intermediates. Discover cost-effective manufacturing and scalable supply chain solutions.
Patent CN107337663A enables metal-free visible light synthesis of 3-thiospirotrienone. Offers green manufacturing, reduced purification costs, and scalable supply chain solutions for pharma intermediates.
Patent CN112939891A reveals a metal-free visible light protocol for biphenyl benzothiazole. This method offers significant cost reduction and simplified supply chains for pharmaceutical intermediates.
Patent CN117088826B enables visible light oxazole synthesis. Offers green chemistry benefits and supply chain stability for pharmaceutical intermediate manufacturing.
Patent CN112778191A details a green photocatalytic route for indole allyl alcohols, offering high yield and mild conditions for reliable pharmaceutical intermediate supply.
Discover the novel photocatalytic synthesis of heterocyclic cyclopropanes from patent CN112898202B. A mild, high-yield route for pharmaceutical intermediates manufacturing.
Patent CN114874139A details a green visible-light method for synthesizing 1-benzyl-3,4-dihydroisoquinolines, offering cost-effective routes for pharmaceutical intermediates.
Patent CN108456227A reveals visible-light synthesis for high-purity fluorosulfonyl phosphonates. Enables cost reduction and scalable manufacturing for enzyme inhibitors.
Patent CN117126077B reveals a green visible-light iron catalyzed route for 4-arylbutyronitrile. Achieve 100% atom economy and cost reduction in fine chemical manufacturing.
Patent CN106467481B enables visible-light synthesis of indole ketones without transition metals, offering cost reduction and high purity for pharmaceutical manufacturing supply chains.
Patent CN112409275B reveals a green photocatalytic route for 3-acylquinoxalinones using visible light and eosin Y, offering cost-effective pharma intermediate manufacturing.
Patent CN114213254B details a novel photoredox method for beta-nitroketones. Enables cost reduction in pharmaceutical intermediate manufacturing with high yields.
Patent CN112142680B details a metal-free photocatalytic route for 3-trifluoroalkylquinoxalinones, offering cost-effective and scalable manufacturing for pharmaceutical intermediates.
Patent CN111925308B reveals a mild iridium-catalyzed photocatalytic route for N-substituted sulfone diimines, offering reliable pharmaceutical intermediate supply chains.
This patent reveals a novel visible-light-driven iron-catalyzed method for aryl benzyl sulfide synthesis, offering enhanced substrate scope and milder conditions for reliable pharmaceutical intermediate production.
Novel visible-light photocatalytic method for sulfuryl gamma-lactone synthesis enabling high-purity pharmaceutical intermediates with improved supply chain reliability and cost efficiency.
Patent CN109053625B enables mild visible-light synthesis of benzothiazole derivatives eliminating transition metals to reduce costs and enhance supply chain reliability for pharmaceutical intermediates.